DelSite Biotechnologies, Inc. (OTC BB: DSII), an ISO 9001-certified, research-based, biopharmaceutical and consumer products company, has a core technology based on naturally-occurring complex carbohydrates. The company is focused on manufacturing and marketing consumer products as well as manufacturing quality products for other companies. Its proprietary GelSite(r) technology is protected by more than 130 patents in 26 countries. For further information, visit the Company’s web site at www.delsite.com.
- 18 years ago
QualityStocks
DelSite Biotechnologies, Inc. (OTC BB: DSII)
Tags Rodman & Renshaw
Related Post
-
Quantum BioPharma Ltd. (NASDAQ: QNTM) Pursues a New Path for Better Multiple Sclerosis Treatments
In the United States alone, close to one million people are living with MS, with…
-
Why Verbal Skills Aren’t Enough: WRAP’s New Doctrine Aims to Give Officers a Lawful Next Step
California's SB 230 requires agencies to incorporate de-escalation and alternatives to force into their use-of-force…
-
Beeline Holdings Inc. (NASDAQ: BLNE) Partners with Loft 100 Studios to Examine the Mortgage Market and New Approaches to Homeownership
The partnership will focus on the production of a 45-minute “Bizumentary” examining current challenges and…